REGENXBIO Inc. (RGNX) vs YD Bio Limited (YDES)

REGENXBIO Inc. RGNX 6.93 −3.21%
YD Bio Limited YDES 5.92 −12.17%

REGENXBIO Inc. and YD Bio Limited are both Biotechnology companies. REGENXBIO Inc. and YD Bio Limited are of similar size ($477.5M and $472.7M).

Metric	RGNX	YDES	Biotechnology median
P/E	n/m	—	8.50
P/S	2.10	—	9.71
P/B	5.10	—	2.13
Price to free cash flow	n/m	—	20.82
EV/EBITDA	n/m	—	0.64
EV/Sales	1.53	—	9.21
Earnings yield	(54.69%)	—	(33.15%)
Free cash flow yield	(68.21%)	—	(25.50%)

Metric	RGNX	YDES	Biotechnology median
Gross margin	86.38%	—	65.16%
Operating margin	(94.08%)	—	0.00%
Net margin	(112.58%)	—	0.00%
Free cash flow margin	(143.09%)	—	0.00%
Return on equity	(137.63%)	—	(56.36%)
Return on assets	(40.60%)	—	(48.04%)
Return on invested capital	0.00%	—	0.00%

Metric	RGNX	YDES	Biotechnology median
Revenue growth (TTM)	12.00%	—	6.02%
EPS growth (last fiscal year)	18.08%	—	30.26%
Revenue growth, 5-year CAGR	1.97%	—	9.41%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	RGNX	YDES	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	2.86	—	4.72
Net debt to EBITDA	1.58	—	0.96

Metric	RGNX	YDES	Biotechnology median
Dividend yield	—	—	0.09%
Payout ratio	—	—	—

Metric	RGNX	YDES	Biotechnology median
Market cap	472.65m	477.48m	135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack